# Bortezomib

NDC: 31722-303
Generic name: Bortezomib
Labeler / Manufacturer: Camber Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20240503

FDA application: ANDA212204

## Active ingredients

- BORTEZOMIB: 3.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"31722-303"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=31722-303
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=04aafa6a-a50d-4a47-a831-be8e8bb992ac